Correlation Between SentinelOne and Arcturus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SentinelOne and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SentinelOne and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SentinelOne and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on SentinelOne and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SentinelOne with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SentinelOne and Arcturus Therapeutics.

Diversification Opportunities for SentinelOne and Arcturus Therapeutics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SentinelOne and Arcturus is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding SentinelOne and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and SentinelOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SentinelOne are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of SentinelOne i.e., SentinelOne and Arcturus Therapeutics go up and down completely randomly.

Pair Corralation between SentinelOne and Arcturus Therapeutics

Taking into account the 90-day investment horizon SentinelOne is expected to generate 0.46 times more return on investment than Arcturus Therapeutics. However, SentinelOne is 2.16 times less risky than Arcturus Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about 0.04 per unit of risk. If you would invest  2,601  in SentinelOne on September 2, 2024 and sell it today you would earn a total of  194.00  from holding SentinelOne or generate 7.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SentinelOne  vs.  Arcturus Therapeutics Holdings

 Performance 
       Timeline  
SentinelOne 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SentinelOne are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, SentinelOne unveiled solid returns over the last few months and may actually be approaching a breakup point.
Arcturus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcturus Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Arcturus Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

SentinelOne and Arcturus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SentinelOne and Arcturus Therapeutics

The main advantage of trading using opposite SentinelOne and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SentinelOne position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.
The idea behind SentinelOne and Arcturus Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities